ENYO Pharma global scientific approach is inspired from the virus strategy to hijack cellular functions without endangering the cell. In order to exploit, inhibit or modify these cellular functions, viruses interact with various cellular proteins of their host implied in a wide range of pathways through their own viral proteins.
ENYO Pharma is using phenotypic screens (mainly using viruses as screening tools, but also bacteria and cancer cell as well as in house reporter cell lines) to test its peptidic and small molecules libraries with a total agnostic approach regarding the target. By targeting human proteins, ENYO Pharma has the opportunity to extend therapeutic application beyond infectious diseases.
This disruptive host-targeted approach is applicable to a broad range of diseases (infectious diseases, metabolic diseases, oncology…) with unmet medical needs.